Top 4 NYSE Stocks In The Medical Instruments & Supplies Industry With The Highest Revenue Estimates

Below are the top medical instruments & supplies stocks on the NYSE in terms of revenue estimate for the current year.

Analysts expect Baxter International (NYSE: BAX) to post revenue of $15.62 billion for the year ending December, 2013. Baxter's trailing-twelve-month revenue is $14.19 billion.

Thermo Fisher Scientific (NYSE: TMO) is likely to post revenue of $12.97 billion in the year ending December, 2013. Thermo Fisher Scientific's PEG ratio is 1.17.

Covidien plc (NYSE: COV) is expected to report revenue of $12.57 billion for the year ending September, 2013. Covidien had $1.40 billion in total cash for the latest quarter.

Becton, Dickinson and Company (NYSE: BDX) may report revenue of $8.01 billion in the year ending September, 2013. Becton, Dickinson's trailing-twelve-month ROE is 24.60%.